NCT07749079

Brief Summary

The goal of this observational study is to learn how often postoperative nausea and vomiting occur in adults undergoing nasal surgery under general anesthesia and to identify factors associated with these events. The study will also describe other postoperative complications and factors that may affect recovery. The main questions it aims to answer are:

  • How many participants experience nausea, retching, or vomiting within 24 hours after surgery?
  • Which patient characteristics, anesthesia-related factors, surgical factors, and perioperative medications are associated with postoperative nausea and vomiting?
  • What other postoperative complications and nasal-related symptoms occur after surgery? Approximately 1,000 adults undergoing nasal surgery under general anesthesia at three hospitals in China will be enrolled. This is an observational study, and participation will not change the anesthesia, surgery, medications, or other medical care selected by the treating clinical team. Participants will:
  • Complete assessments before surgery about their medical history, previous nausea or vomiting, anxiety, sleep, and recovery status
  • Receive routine anesthesia and surgical care
  • Be assessed for nausea, retching, vomiting, pain, nasal discomfort, and other complications during the first 24 hours after surgery
  • Complete follow-up assessments after surgery, including follow-up by telephone after discharge, for up to 6 months The study will use information from participant questionnaires, medical records, anesthesia records, and postoperative follow-up assessments.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
11mo left

Started Aug 2026

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress2%
Aug 2026Jun 2027

First Submitted

Initial submission to the registry

July 20, 2026

Completed
12 days until next milestone

Study Start

First participant enrolled

August 1, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 6, 2026

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2027

Last Updated

August 6, 2026

Status Verified

August 1, 2026

Enrollment Period

5 months

First QC Date

July 20, 2026

Last Update Submit

August 1, 2026

Conditions

Keywords

Postoperative nausea and vomitingPONVNasal surgeryGeneral anesthesiaRisk factorsProspective cohort studyPerioperative complications

Outcome Measures

Primary Outcomes (1)

  • Incidence of Postoperative Nausea and Vomiting Within 24 Hours

    The proportion of participants who experience any episode of nausea, retching, or vomiting during the first 24 hours after surgery. Postoperative nausea and vomiting will be assessed during the following intervals: 0-2 hours, 2-6 hours, 6-12 hours, and 12-24 hours after anesthesia induction. A participant will be considered to have postoperative nausea and vomiting if nausea, retching, or vomiting occurs at any time during the 24-hour observation period.

    From the end of surgery through 24 hours after surgery

Secondary Outcomes (13)

  • Incidence of Clinically Significant Postoperative Nausea and Vomiting

    At 6 hours, 24 hours, and postoperative day 3

  • Incidence of Vomiting or Retching Within 24 Hours

    From the end of surgery through 24 hours after surgery

  • Number of Vomiting or Retching Episodes Within 24 Hours

    From the end of surgery through 24 hours after surgery

  • Use of Rescue Antiemetic Medication

    From the end of surgery through postoperative day 3

  • Severity of Postoperative Pain

    At 0-2 hours, 2-6 hours, 6-12 hours, 12-24 hours, postoperative day 3, and postoperative day 30

  • +8 more secondary outcomes

Study Arms (1)

Adults Undergoing Nasal Surgery Under General Anesthesia

This prospective observational cohort includes adults aged 18 years or older undergoing nasal surgery under general anesthesia. No study-specific intervention will be administered. Anesthetic management, surgical care, prophylactic antiemetic therapy, analgesia, and postoperative treatment will be determined by routine clinical practice at each participating center. Perioperative patient, anesthesia, surgical, and medication-related factors will be recorded, and participants will be followed to assess postoperative nausea and vomiting and other postoperative complications.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population consists of adult patients (≥18 years) scheduled to undergo elective nasal surgery under general anesthesia at three tertiary hospitals in China. Consecutive eligible patients who provide written informed consent will be enrolled in this multicenter prospective observational cohort study to evaluate the incidence and risk factors for postoperative nausea and vomiting.

You may qualify if:

  • Scheduled to undergo nasal surgery under general anesthesia
  • Aged 18 years or older
  • Willing and able to provide written informed consent

You may not qualify if:

  • Unable to cooperate with study procedures or complete study assessments for any reason, including language barriers, cognitive impairment, or inability to complete the questionnaires
  • Considered unsuitable for participation by the investigator

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Postoperative Nausea and Vomiting

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsNauseaSigns and Symptoms, DigestiveSigns and SymptomsVomiting

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, Chief Physician, Director of the Department of Anesthesiology

Study Record Dates

First Submitted

July 20, 2026

First Posted

August 6, 2026

Study Start

August 1, 2026

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

June 30, 2027

Last Updated

August 6, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will share

De-identified individual participant data will be shared through the SDB platform (https://www.scidb.cn/en) under controlled access. Access will be granted to qualified researchers whose research proposals are scientifically and ethically appropriate and approved according to the SDB data access procedures. Data users may be required to sign a data use agreement before access is granted.

Shared Documents
CSR, ANALYTIC CODE